期刊文献+

可溶性人白细胞抗原-Ⅰ临床研究现状 被引量:1

The Current Clinical Study on sHLA-Ⅰ
原文传递
导出
摘要 可溶性人白细胞抗原(sHLA)Ⅰ在体内参与免疫应答,可诱导产生免疫耐受,抑制细胞毒性T淋巴细胞(CTL)的溶细胞作用。在器官组织移植、感染性疾病、自身免疫性疾病及肿瘤分化中具有重要的免疫调节作用。 Soluble human leucocyte antigen-1 is involved in immunological reactions, such as immune tolerance and preventing CTL-mediated cytolysis. It plays an important role in organ/tissue transplant, inflammatory disease, autoimmune disease, and tumor differentiation.
出处 《国际免疫学杂志》 CAS 2006年第2期123-125,128,共4页 International Journal of Immunology
关键词 可溶性人白细胞抗原 自然杀伤细胞 子宫内膜异位症 肿瘤 Soluble human leucocyte antigen- 1 ( sHLA-Ⅰ ) Natural killer cell Endometriosis tumor
  • 相关文献

参考文献3

二级参考文献16

  • 1Higuchi A, Hagihara M, Tsumuraya N, et al. Comparison of soluble and membrane bound HLA-class Ⅰ and DR levels in umbilical cord blood and adult peripheral blood [J]. Tokai J Exp Clin Med, 2003,28(1): 1-7.
  • 2Bjorkman PJ, Saper MA, Samraoui B, et al. Structure of the human class Ⅰ histocompatibility antigen, HLA-A2 [J]. J Immunol, 2005,174(1): 6-19.
  • 3Maller J, Scheck M, Zipfel A, et al. Influence ofperioperative sHLA-Ⅰ concentration on the histological development of the liver graft [J].Transpl Int, 2000, 13(Suppl 1): S449-51.
  • 4Sediva A, Stary J, Hromadrikova I, et al. Determination of soluble HLA class Ⅰ molecules in children in boon marrow transplantation[J]. Cas Lek Cesk, 2000, 139(20): 630-4.
  • 5Koelman CA, Vaemen IM, Balk AH, et al. Donor-derived soluble HLA plasma levels can not be used tomonitor graft rejection in heart transplant recipiects[ J ]. Transpl Immunol, 2000, 8(1): 57-64.
  • 6Burlingham WJ, Class FH. Soluble MHC in allograft recipients [J].Hum Immunol, 1999, 60(5): 401-2.
  • 7Risso M, Sundiresan S, Lynch J, et al. Increased concentration of soluble human leukocyte antigue class Ⅰ levels in the bronchoalveolar larage of human pulmonary allograft [J]. J Heart Lung Transplant, 1997, 16(11): 1135-40.
  • 8Zavazava N. Soluble HLA class Ⅰ molecules: biological significance and clinical implications[J]. Mol Med Today, 1998, 4(3): 116-21.
  • 9Liem LM, Koelman CA, Doxiadis N,etal. Elevated serum HLA class I levels coincide with acute and chronic graft-versus-host disease[J]. Bone Marrow Transplant, 1997, 20(1): 227-34.
  • 10PoulettyP,FerroneS,AmeslandF,etal.ummaryreportfromthefirstin ternationalworkshoponsolubleHLAantigensParis,August1992[].TissueAutigens.1993

共引文献14

同被引文献10

  • 1徐若男,黎燕(审校者).重症肌无力发病机理的研究进展[J].国际免疫学杂志,2006,29(1):14-17. 被引量:8
  • 2刘金,蔡荣(审校),钱程(审校).肿瘤基因治疗的策略[J].国际免疫学杂志,2006,29(3):179-184. 被引量:4
  • 3王飞,李辉,温泽清.HLA-G与肿瘤细胞的免疫逃逸[J].中华肿瘤防治杂志,2007,14(22):1751-1754. 被引量:5
  • 4Halloran PF, Reeve JP, Pereira AB, et al. Antibody-mediated rejec- tion, T cell-mediated rejection, and the injury-repair response : new insights from the Genome Canada studies of kidney transplant biopsies [ J ]. Kidney Int, 2014,85 ( 2 ) :258-264.
  • 5Zou HY, Yu WZ, Wang Z, et al. Human leukocyte antigen-B27 al- leles in Xinjiang Uygur patients with ankylosing spondylitis [ J ]. Genet Mol Res ,2015, 14 ( 2 ) :5652-5657.
  • 6Batalla A, Coto E, Gonz61ez-Fern(andez D, et al. The Cw6 and late- cornified envelope genotype plays a significant role in antl-tumor necrosis factor response among psoriatic patients [ J ]. Pharmacogen- et Genomics,2015,25(6) :313-316.
  • 7Winiewski A, Kowal A, Wyrodek E, et al. Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1 ,in non-small ceil lung cancer[ J ]. Tissue Antigens ,2015, 85 (6) :466-475.
  • 8Aureli A,Canossi A,Del Beato T,et al. HLA-DRB1 * 13:01 allele in the genetic susceptibility to colorectal carcinoma[ J]. Int J Canc- er,2015,136 ( 10 ) :2464-2468.
  • 9Jin YJ,Shim JH,Chung YH,et al. Relationship of HLA-DRB1 al- leles witla hepatocellular carcinoma development in chronic hepati- tis B patients [ J ]. J Clin Gastroenterol, 2012,46 ( 5 ) :420 -426.
  • 10唐秋莎,张建琼.HLA-Ⅱ类分子与肿瘤[J].微生物学免疫学进展,2002,30(4):65-68. 被引量:7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部